NIST Advanced Technology Program
Return to ATP Home Page
Meet Our Staff Meet with ATP CLSO Staff In Your Area Search for an CLSO Funded Project New Directions E-mail comments Related Links CLSO Home Page
ATC Workshop Papers

From Cell to Production

Technical Challenges of Cloning Pigs for BioMedical Research

Somatic Cell Nuclear Transfer in Mammals

SATACs and Transgenesis

Concerns About Gene Transfer and Nuclear Transfer in Domestic Animals

Prospects and Hurdles in Optimizing the Vascular Support of Engineered Tissues

ES Cells Make Neurons in a Dish

Nuclear Transfer and Gene Targeting in Domestic Animals: Bioreactors of the Future

Application of Nuclear Transfer Technology in the Generation of Pigs for Xenetransplantation

Genomics: Delivering Cell Culture Systems for Tissue Therapy

Nuclear Transfer Technology

Homologous Recombination and Genetic Engineering of Transgenic Recombinant Animals

Nuclear Transplantation in the Cow: Future Challenges

Enhancing Transgenics through Cloning

ES Cells Offer is a Power Tool for Understanding the Genetic Control of Tissue Development and for Screening Potential Therapeutic Drugs

Human Germline Engineering -- The Prospects for Commercial Development

Mammalian Artificial Chromosomes for Animal Transgenesis

Understanding Developmental Abnormalities in Offspring Produced by Nuclear Transplantation

Role of Cell Cycle

Cloning and Other Reproductive Technologies for Application in Transgenics

Cell Culturing Technology as a Major Hurdle in the Commercialization of Genetically Altered Animals

    ADVANCED TRANSGENESIS AND CLONING: Genetic Manipulation in Animals
Electronic Workshop Presentation: Paper No. 12

GENE TARGETING IN THE PORCINE AND BOVINE SPECIES: CHALLENGES AND OPPORTUNITIES

Participant:

    Jorge A. Piedrahita
    Center for Animal Biotechnology
    Texas A&M University
    College Station, TX. 77843

In contrast to the highly developed genetic modification systems available for manipulating the mouse genome, at this time only simple gain of function modifications can be readily undertaken in domestic species. This is due to the limited concerted effort in developing gene targeting technology in domestic species, as well as technical barriers unique to the bovine and porcine. Clearly the greatest barrier to gene targeting in these two species is the unavailability of cell lines that can be readily modified in vitro and still be used to generate a living organism. In the mouse, the embryonic stem (ES) cells and embryonic germ (EG) cells have fulfilled that role. In addition to the absence of easily manipulated cell lines, targeting in the bovine and porcine species is affected by the need to develop targeting constructs containing isogenic DNA regions. As a result it is not possible to generate genomic libraries from a particular breed, and isolate genes from that library to develop effective targeting constructs. Instead, it is necessary to isolate the gene of interest, sequence required regions, and develop isogenic targeting constructs by technologies such as long-range PCR, thus increasing the time frame and costs required to develop a targeting construct.

With regards to pluripotent/totipotent cell lines, in spite of considerable efforts it has not been possible to establish ES cell lines in the bovine and porcine that can be used to introduce genetic modifications into the germ line. Fortunately, in the case of the bovine species, advances in cloning by nuclear transfer indicate that fetal fibroblasts can be manipulated in vitro and still be used to generate a normal offspring. In order to test the use of fibroblasts as targets for homologous recombination we isolated the bovine PrP gene, and obtained sequence information necessary for generation of targeting constructs. Utilizing isogenic DNA, targeting constructs were made and introduced into fetal fibroblasts by electroporation. Transgenic colonies are being analyzed for the presence of the targeted allele. By far the greatest problem affecting the outcome of this experiment is the inability to maintain the fetal fibroblasts in a proliferative state for longer than 25-30 doublings. This, combined with the lower targeting efficiency of somatic cells versus embryonic stem cells, makes identification of targeted clones extremely difficult. It is clear, therefore, that for wide applicability of the technology cell lines that can be used for the cloning procedure but can also be cultured for greater than 30 doublings are required. Alternately, gene targeting system of much greater efficiency than the existing ones need to be developed to ensure than even with a limited cellular life span, targeted events are identified.

Although it is likely that the cloning procedure will soon be applicable to swine, at this time the only available option for precise genetic modification in this species is the use of EG cell lines. Recently, we have been able to isolate EG cells from swine, and utilize them for the generation of transgenic chimeras. While these cell lines may be of use as carrier systems, they are difficult to maintain, have low cloning efficiency, and require the generation of chimeras before a founder can be established; an additional generation that can have significant economic impact in species with relatively long gestation and reproductive maturity periods. However, in contrast to fetal fibroblast, they do not readily undergo senescence and can be maintained for prolonged periods of time, although with some loss of undifferentiated characteristics. Additionally, they may be of use for favoring entrance into the germ line by use of tetraploid embryos for chimera generation, or by using the cells as nuclear donors in a cloning procedure.

While at this time the greatest barriers to the application of this technology are mostly technical, it is likely that with a concerted effort and federal support most if not all of these barriers will soon be overcome. Thus, it is critical that in parallel with efforts to complete development of the technology, efforts to identify single genes that can have significant economic impact in phenotypes of agricultural importance, such as muscle composition and disease resistance, must be supported. Otherwise, we run the risk of ending up with a technique for manipulating genes but no genes to manipulate.

Click here to post comments on participants' workshop paper.

Click here for PUBLIC Discussion Group

previous Return to previous workshop paper.             next Go to next workshop paper

DOOR Return to ATC's Main Page

Return to ATP Home Page ATP website comments: webmaster-atp@nist.gov   /  Technical ATP inquiries: InfoCoord.ATP@nist.gov.

NIST is an agency of the U.S. Commerce Department
Privacy policy / Security Notice / Accessibility Statement / Disclaimer / Freedom of Information Act (FOIA) /
No Fear Act Policy / NIST Information Quallity Standards / ExpectMore.gov (performance of federal programs)
Return to NIST Home Page
Return to ATP Home Page Return to NIST Home Page Go to NIST Home Page